Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Assessment of Planning Target Volume Margin for a Small Number of Vertebral Metastatic Lesions Using Image-guided Intensity-modulated Radiation Therapy by Helical Tomotherapy

TAKUYA NISHIMURA, HIDEYA YAMAZAKI, KAZUKI IWAMA, TOMOYA KOTANI, YOSHITAKA OOTA, HIRONORI AIBE, SATOAKI NAKAMURA, HIROYASU IKENO, KEN YOSHIDA, FUMIAKI ISOHASHI and HARUUMI OKABE
Anticancer Research June 2013, 33 (6) 2453-2456;
TAKUYA NISHIMURA
1Department of Radiology, Ujitakeda Hospital, Uji-city, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIDEYA YAMAZAKI
1Department of Radiology, Ujitakeda Hospital, Uji-city, Kyoto, Japan
2Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hideya10{at}hotmail.com
KAZUKI IWAMA
1Department of Radiology, Ujitakeda Hospital, Uji-city, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMOYA KOTANI
3Department of Radiology, Matsushita Memorial Hospital, Moriguchi-city, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHITAKA OOTA
2Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIRONORI AIBE
1Department of Radiology, Ujitakeda Hospital, Uji-city, Kyoto, Japan
2Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SATOAKI NAKAMURA
1Department of Radiology, Ujitakeda Hospital, Uji-city, Kyoto, Japan
2Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROYASU IKENO
2Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KEN YOSHIDA
4Department of Radiology, Osaka Medical College, Takatsuki-City, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FUMIAKI ISOHASHI
5Department of Radiation Oncology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HARUUMI OKABE
1Department of Radiology, Ujitakeda Hospital, Uji-city, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Aim: To evaluate an appropriate planning target volume (PTV) margin in for one to three vertebral metastases using megavolt computed tomography (MVCT) images during the course of image-guided and stereotactic intensity-modulated radiotherapy (IGRT-IMRT) by use of helical tomotherapy. Patients and Methods: A total of 25 lesions in 24 patients with vertebral metastases who received IGRT-IMRT were analyzed. MVCT images were acquired before and after radiation therapy. Intra-fractional movement and PTV margin were calculated by comparing treatment planning images and these 310 MVCT images for right-left (RL), superior-inferior (SI), and anteroposterior (AP) dimensions. Five patients were treated by 35 Gy/5 fractions, 17 by 30 Gy/5 fractions, one by 25 Gy/5 fractions, and one by 60 Gy/30 fractions. A margin to compensate for these variations was calculated with the formula of vanHerk's equation. Results: The intra-fractional motion was 0.02 (−1.3 to 1.4) ± 0.34 mm in the RL direction, −0.09 (−1.8 to 0.28) ± 0.44 mm in the SI direction, and 0.20 (−1.8 to 1.8) ± 0.36 mm in the AP direction. The required PTV margin was 0.98 mm in the RL direction, 0.69 mm in the SI direction, and 1.26 mm in the AP direction. No patient showed a deviation greater than 2 mm. Conclusion: The PTV margin in hypofractionated IGRT–IMRT, using helical tomotherapy for a few vertebral metastases, was 2 mm or less and our tentative PTV margin of 5 mm was sufficient and reducible.

  • Tomotherapy
  • vertebral body metastases
  • stereotactic body radiotherapy
  • PTV margin
  • image-guided IMRT

Radiation therapy is a common and effective treatment modality for managing skeletal metastases. The possible irradiated dose to vertebral metastases is limited for tumors located near the spinal cord when conventional external beam techniques are used. Recent advances in technology have improved the therapeutic threshold, permitting delivery of an ablative radiation dose using an image-guided stereotactic approach (1). In addition, in the era of modern radiotherapy techniques, the planned target volume (PTV) to vertebral metastases can be reduced by precise positioning, i.e. by image-guided and stereotactic intensity-modulated radiotherapy (IGRT–IMRT) (2). Because helical tomotherapy has the ability to acquire megavoltage computed tomographic (MVCT) images of a patient in the treatment position before each treatment, daily imaging can minimize daily positional uncertainties (2). This precise positioning allows the PTV to be reduced, directly improving conformal avoidance of nearby critical structures. Therefore, we initiated an assessment of the required PTV margin in IGRT–IMRT for a few vertebral metastases using helical tomotherapy.

Patients and Methods

We evaluated 25 lesions in 24 patients with one to three vertebral metastases who received IGRT–IMRT using helical tomotherapy (HI-ART TomoTherapy Inc., Madison, WI, USA) between December 2007 and February 2009. Patient characteristic are shown in Table I. One patient was treated for cervical and lumber spine twice. Vacuum cushions (Blue Bag, Medical Intelligence, Schwabműenchen, Germany) were used to immobilize the patients in a supine position. Custom Aquaplast masks (WFR Aquaplast, Inc., Avondale, PA, USA) were also used to immobilize the patients with cervical spine targets.

Kilovoltage CT images were acquired for each patient (2-mm slice thickness) at least 5 cm above and below the level of PTV. The spinal cord was defined as an organ at risk. The gross tumor volume was contoured; the vertebral body was contoured as a clinical target volume (CTV), which was expanded into the PTV by adding a uniform 5-mm margin around the CTV and subtracting the cord volume at risk. The dose was set as D95: 95% of the PTV was to receive the prescribed dose. Five patients were treated by 35 Gy/5 fractions, 17 by 30 Gy/5 fractions, one by 25 Gy/5 fractions, and one by 60 Gy/30 fractions. The maximum dose to the spinal cord was set with the highest inverse priority so that the total cord dose did not exceed 50 Gy (BED2Gy=n × d × (α/β + d)/(α/β + 2), where BED=biological equivalent dose, n=number of fractions, d=fraction dose, and α/β=2). The patients were then positioned for each delivery fraction on the HI-ART table and aligned using wall-mounted lasers.

MVCT using 3.5-MV energy images were acquired through PTV before treatment delivery with the minimum slice thickness (4 mm) and field of view (35 cm). The first MVCT images were taken and autofused with the kV CT treatment planning images, and the superior–inferior (SI), anterior–posterior (AP), and right–left (RL) shifts were calculated by automatic image fusion and then manually verified and corrected by two of the authors (rotational corrections were not implemented at the time of this study). The patients were then shifted along calculated couch translations. For the initial 12 lesions of 11 patients, MVCT (second MCVT) images were acquired to verify that the shifts were correctly applied. The images were manually inspected by two of the authors, and the patients were then re-adjusted (if necessary) and treated. The third MVCT image was taken to assess intrafractional organ motion after radiation therapy. The total time between image acquisition and treatment delivery was typically less than 10 min. Intrafractional movement was calculated by comparing the second and third MVCT images. The second MVCT images were omitted because little displacement (<1 mm) was found between the second MVCT image and the expected location by the shifts applied. Thereafter, the first and third MVCT images were used to calculate intrafractional organ motion in the subsequent 13 lesions in 13 patients. Intrafractional movement was calculated by comparing the expected location by the shifts applied to the first and third MVCT image locations. vanHerk's formula (2.5Σ + 0.7σ, where Σ and σ were systematic and random positioning errors, respectively) was used to calculate the PTV margin to compensate for these variations (3).

Results

Five patients were treated with 35 Gy/5 fractions, 17 by 30 Gy/5 fractions, one by 25 Gy/5 fractions, and one by 60 Gy/30 fractions. In each patient, five fractions were examined by repeated MVCT, and the 310 MVCT images were analyzed for deviations. Intrafractional motion was 0.02 mm (−1.3 to 1.4 mm) ± 0.34 mm in the RL direction (right direction regarded as positive), −0.09 mm (−1.8 mm to 0.28 mm) ± 0.44 mm in the SI direction (superior direction regarded as positive), 0.20 mm (−1.8 mm to 1.8 mm) ± 0.36 mm in the AP direction (anterior direction regarded as positive). In detail, the intrafractional motions in the RL, SI, and AP directions for the cervical spine were 0.3 mm ± 0.38 mm, −0.05 mm ± 0.37 mm, and −044 mm ± 0.56 mm, respectively; for the thoracic spine, 0.02 mm ± 0.30 mm, −0.17 mm ± 0.47 mm, and 0.24 mm ± 0.40 mm, respectively; and for the lumber spine, −0.17 mm ± 0.23 mm, 0.14 mm ± 0.34 mm, and 0.25 mm ± 0.23 mm, respectively. No patient showed a deviation greater than 2 mm (Figure 1). Therefore, the required PTV margin was 0.98 mm in the RL direction, 0.69 mm in the SI direction, and 1.26 mm in the AP direction. All patients were treated without any adverse effects.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Patients' characteristics.

Discussion

In contrast to the relatively disappointing outcomes reported with conventional fractionation or low-dose single-fraction radiotherapy, high-dose single or fractionated radiation therapy was shown to be highly effective in the palliation of metastatic spinal cord tumors (4). Gerszten and Welch reported on 500 patients with paraspinal lesions treated with 12-25 Gy (maximal intratumoral dose) single-fraction radiation therapy (5). Stereotactic radiosurgery was the primary treatment modality for the spinal lesions in 65 patients. The control of symptoms was excellent; 86% of the patients reported decrease in pain and 90% were reported to have local control. Toxicity was minimal, including no treatment-related myelopathy. Similar favorable results have also been reported by several others (6-9). Following those results, we initiated IGRT–IMRT in patients with a few vertebral metastases.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Distribution of intra-fractional motion. No patient showed deviation larger than 2 mm. AP: Anterior–posterior; RL: right–left; SL: superior–inferior.

Hyde et al. reported that the absolute intra-fractional motion averaged over all directions along the x, y, and z axes (SD) were 0.7±0.5 mm and 0.5±0.4 mm for the 1.5- and 1-mm tolerances, respectively. On the basis of a 1-mm and 1 correction threshold, the target was localized to within 1.2 mm and 0.9 mm, respectively, with 95% confidence using Cyberknife (10). These values are consistent with our results. Mahan et al. reported that anthropomorphic phantom studies indicated that MVCT images in tomotherapy were capable of imaging the spine with sufficient accuracy to place the isocenter within 1 mm of the desired position (2). Our results showed that the required maximal PTV margin was 1.26 mm in the AP direction. Therefore 2.26 mm margin (1.26 + 1 mm) for the PTV is enough to compensate for image ambiguity.

One of the limitations of this study was that we applied vanHerk's equation because it is a widely known formula for conventional multifractionation radiotherapy, although here it was used for hypofractionated stereotactic radiation therapy. Even so, no patient showed a deviation greater than 2 mm; thus, our tentative 5-mm PTV margin was sufficient for IGRT–IMRT for cases with few vertebral metastases.

In conclusion, the PTV margin in hypofractionated IGRT–IMRT using helical tomotherapy for a few vertebral metastases could be 2 mm or less. Our tentative PTV margin of 5 mm was sufficient and reducible, if required.

  • Received March 12, 2013.
  • Revision received May 2, 2013.
  • Accepted May 8, 2013.
  • Copyright© 2013 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Hall WA,
    2. Stapleford LJ,
    3. Hadjipanayis CG,
    4. Curran WJ,
    5. Crocker I,
    6. Shu HK
    : Stereotactic body radiosurgery for spinal metastatic disease: an evidence-based review. Int J Surg Oncol 2011; 979214, 2011.
  2. ↵
    1. Mahan SL,
    2. Ramsey CR,
    3. Scaperoth DD,
    4. Chase DJ,
    5. Byrne TE
    : Evaluation of image-guided helical tomotherapy for the retreatment of spinal metastasis. Int J Radiat Oncol Biol Phys 63: 1576-1583, 2005.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Yamada Y,
    2. Bilsky MH,
    3. Lovelock DM,
    4. Venkatraman ES,
    5. Toner S,
    6. Johnson J,
    7. Zatcky J,
    8. Zelefsky MJ,
    9. Fuks Z
    : High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys 71: 484-490, 2008.
    OpenUrlCrossRefPubMed
  4. ↵
    1. van Herk M
    : Errors and margins in radiotherapy. Semin Radiat Oncol 14: 52-64, 2004.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Gerszten PC,
    2. Burton SA,
    3. Belani CP,
    4. Ramalingam S,
    5. Friedland DM,
    6. Ozhasoglu C,
    7. Quinn AE,
    8. McCue KJ,
    9. Welch WC
    : Radiosurgery for spinal metastases: Clinical experience in 500 cases from a single institution. Spine 32: 193-199, 2007.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Gibbs IC,
    2. Kamnerdsupaphon P,
    3. Ryu MR,
    4. Dodd R,
    5. Kiernan M,
    6. Chang SD,
    7. Adler JR Jr..
    : Image-guided robotic radiosurgery for spinal metastases. Radiother Oncol 82: 185-190, 2007.
    OpenUrlCrossRefPubMed
    1. Chang EL,
    2. Shiu AS,
    3. Mendel E,
    4. Mathews LA,
    5. Mahajan A,
    6. Allen PK,
    7. Weinberg JS,
    8. Brown BW,
    9. Wang XS,
    10. Woo SY,
    11. Cleeland C,
    12. Maor MH,
    13. Rhines LD
    : Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine 7: 151-160, 2007.
    OpenUrlCrossRefPubMed
    1. Nieder C,
    2. Grosu AL,
    3. Andratschke NH,
    4. Molls M
    : Update of human spinal cord reirradiation tolerance based on additional data from 38 patients. Int J Radiat Oncol Biol Phys 66: 1446-1449, 2006.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Rades D,
    2. Stalpers LJ,
    3. Veninga T,
    4. Hoskin PJ
    : Spinal reirradiation after short-course RT for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 63: 872-875, 2005.
    OpenUrlPubMed
  8. ↵
    1. Hyde D,
    2. Lochray F,
    3. Korol R,
    4. Davidson M,
    5. Wong CS,
    6. Ma L,
    7. Sahgal A
    : Spine stereotactic body radiotherapy utilizing cone-beam CT image-guidance with a robotic couch: Intrafraction motion analysis accounting for all six degrees of freedom. Int J Radiat Oncol Biol Phys 82: e555-562, 2012.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 33, Issue 6
June 2013
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Assessment of Planning Target Volume Margin for a Small Number of Vertebral Metastatic Lesions Using Image-guided Intensity-modulated Radiation Therapy by Helical Tomotherapy
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 9 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Assessment of Planning Target Volume Margin for a Small Number of Vertebral Metastatic Lesions Using Image-guided Intensity-modulated Radiation Therapy by Helical Tomotherapy
TAKUYA NISHIMURA, HIDEYA YAMAZAKI, KAZUKI IWAMA, TOMOYA KOTANI, YOSHITAKA OOTA, HIRONORI AIBE, SATOAKI NAKAMURA, HIROYASU IKENO, KEN YOSHIDA, FUMIAKI ISOHASHI, HARUUMI OKABE
Anticancer Research Jun 2013, 33 (6) 2453-2456;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Assessment of Planning Target Volume Margin for a Small Number of Vertebral Metastatic Lesions Using Image-guided Intensity-modulated Radiation Therapy by Helical Tomotherapy
TAKUYA NISHIMURA, HIDEYA YAMAZAKI, KAZUKI IWAMA, TOMOYA KOTANI, YOSHITAKA OOTA, HIRONORI AIBE, SATOAKI NAKAMURA, HIROYASU IKENO, KEN YOSHIDA, FUMIAKI ISOHASHI, HARUUMI OKABE
Anticancer Research Jun 2013, 33 (6) 2453-2456;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Local Control and Clinical Outcome of High-risk Pediatric Neuroblastoma Patients After Receiving Multimodality Treatment and Helical Tomotherapy
  • Analysis of Intrafractional Organ Motion by Megavoltage Computed Tomography in Patients with Lung Cancer Treated with Image-guided Stereotactic Body Radiotherapy Using Helical Tomotherapy
  • Frequency and Predisposing Factors for Interfractional Rectal Displacement Requiring Repeated Precaution in Prostate Cancer Patients Treated with Image-Guided Intensity-Modulated Radiation Therapy
  • Analysis of Intrafractional Organ Motion for Patients with Prostate Cancer Using Soft Tissue Matching Image-guided Intensity-modulated Radiation Therapy by Helical Tomotherapy
  • Exceptionally High Incidence of Grade 2-3 Late Rectal Toxicity in Patients with Prostate Cancer Receiving Hypofractionated (2.2 Gy) Soft Tissue-matched Image-guided Intensity-modulated Radiotherapy
  • Google Scholar

More in this TOC Section

  • 6-O-Carboxypropyl-α-Tocotrienol Enhances the Anticancer Effects of Bortezomib Without Suppressing NRF1 and NRF3 in Colorectal Cancer Cells
  • Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer
  • Imipramine Targets Apoptosis, Metastasis, and EGFR/SRC-mediated EMT in Oral Cancer Cells
Show more Experimental Studies

Keywords

  • tomotherapy
  • vertebral body metastases
  • stereotactic body radiotherapy
  • PTV margin
  • image-guided IMRT
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire